Factor VIII Inhibitor and Bronchogenic Carcinoma
- 1 January 1979
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 41 (02) , 291-295
- https://doi.org/10.1055/s-0038-1646648
Abstract
An inhibitor to procoagulant factor VIII (FVIIIC) developed in a patient three years after palliative resection of a bronchogenic carcinoma. The inhibitor was not active against ristocetin cofactor but possibly had some activity against factor XI. It responded to immunosuppressive therapy. This is apparently the first reported association of carcinoma and factor VIII inhibitor.This publication has 5 references indexed in Scilit:
- HETEROGENEITY OF FACTOR-VIII ANTIBODIES - FURTHER IMMUNOCHEMICAL AND BIOLOGIC STUDIES1977
- Acquired von Willebrand Syndrome with Inhibitors Both to Factor VIII Clotting Activity and Ristocetin-Induced Platelet AggregationBritish Journal of Haematology, 1976
- ANTIBODY-INDUCED VONWILLEBRANDS DISEASE - NEWLY DEFINED INHIBITOR SYNDROME1976
- The Measurement of Prothrombin in Plasma: A Case of Prothrombin DeficiencyJournal of Clinical Pathology, 1953
- A NEW METHOD FOR THE DETERMINATION OF FIBRINOGEN IN SMALL SAMPLES OF PLASMA1951